Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Stock Traders Daily
Provider: GlobalData
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Moody affirms all ratings of Novartis AG, outlook stable - Reuters

Thursday, 24 Apr 2014 06:52am EDT 

Novartis AG:Moody affirms all ratings of Novartis, outlook stable - Reuters.Affirmation of Novartis' rating follows analysis of rating implication of proposed four leg transaction announced by Novartis on April 22.This is regarding acquisition of GSK's oncology products, disposal of group's vaccines business (excluding the flu vaccines franchise) to GSK for, creation of consumer healthcare joint venture owned 36.5 pct by Novartis and sale of group's Animal Health business to Eli Lilly.Stable outlook assigned to current rating reflects Moody's expectation that Novartis to maintain financial policy going forward and that group's credit metrics to not drop materially below expectations for current rating pro-forma of the closing of transaction.